Boron Neutron Capture Therapy (Dawonmedax)

N/A

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameBoron Neutron Capture Therapy (Dawonmedax)
Drug Alias NameN/A
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Boron
Mechanisms of ActionBoron neutron capture therapy
TargetsNot applicable
Therapy Area/IndicationsOligodendrogliomaGlioblastomaAstrocytoma +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDawonMedax Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDawonMedax Co Ltd
Active IndicationsN/A
Inactive IndicationsOligodendrogliomaGlioblastomaAstrocytoma +[4

Other Information

ATC CodeN/A
Related LinksN/A